149 related articles for article (PubMed ID: 37748624)
1. Rediscovering the value of fosfomycin trometamol in the era of antimicrobial resistance: A systematic review and expert opinion.
Cai T; Novelli A; Tascini C; Stefani S
Int J Antimicrob Agents; 2023 Dec; 62(6):106983. PubMed ID: 37748624
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
3. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
Ungheri D; Albini E; Belluco G
J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
[TBL] [Abstract][Full Text] [Related]
4. Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial.
Wagenlehner FM; Abramov-Sommariva D; Höller M; Steindl H; Naber KG
Urol Int; 2018; 101(3):327-336. PubMed ID: 30231252
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
[TBL] [Abstract][Full Text] [Related]
6. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
7. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.
Keating GM
Drugs; 2013 Nov; 73(17):1951-66. PubMed ID: 24202878
[TBL] [Abstract][Full Text] [Related]
8. Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: A systematic review and meta-analysis.
Wang T; Wu G; Wang J; Cui Y; Ma J; Zhu Z; Qiu J; Wu J
Int J Antimicrob Agents; 2020 Jul; 56(1):106018. PubMed ID: 32417205
[TBL] [Abstract][Full Text] [Related]
9. Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant
Polat M; Ozkaya-Parlakay A; Tapısız A; Kara SS; Yüksel S
J Chemother; 2022 Apr; 34(2):97-102. PubMed ID: 34286658
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
Patel SS; Balfour JA; Bryson HM
Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
[TBL] [Abstract][Full Text] [Related]
11. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
[TBL] [Abstract][Full Text] [Related]
12. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
[TBL] [Abstract][Full Text] [Related]
13. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
[TBL] [Abstract][Full Text] [Related]
14. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
15. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
[No Abstract] [Full Text] [Related]
16. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
[TBL] [Abstract][Full Text] [Related]
17. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
18. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
Candel FJ; Matesanz David M; Barberán J
Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of uncomplicated urinary tract infections.
Guay DR
Drugs; 2008; 68(9):1169-205. PubMed ID: 18547131
[TBL] [Abstract][Full Text] [Related]
20. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women.
Minassian MA; Lewis DA; Chattopadhyay D; Bovill B; Duckworth GJ; Williams JD
Int J Antimicrob Agents; 1998 Apr; 10(1):39-47. PubMed ID: 9624542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
